Table 2.
Properties of the applied stents and outcomes of the 18 patients treated with self-expandable metallic stents
No | Type of stent | Length of Stent (mm) | Interval Between Stenting and Operat | Migration | Restenting | Additional Application | Outcome |
---|---|---|---|---|---|---|---|
1 | Covered Metalic | 100 | 3 | Yes | Yes* | Dilatation + Submucosal steroid | Alive |
2 | Covered Metalic | 140 | No-operated | No | No | No | Exitus |
3 | Covered Metalic | 100 | 13 | No | No | No | Alive |
4 | Covered Metalic | 100 | 90 | No | No | No | Alive |
5 | Covered Metalic | 100 | No-operated | No | No | No | Alive |
6 | Covered Metalic | 80 | No-operated | No | No | No | Alive |
7 | Covered Metalic | 210 | 19 | No | No | No | Exitus |
8 | Covered Metalic | 210 | 13 | No | No | No | Alive |
9 | Covered Metalic | 210 | 10 | No | No | No | Alive |
10 | Covered Metalic | 210 | 17 | No | No | No | Alive |
11 | Non-Covered Methalic | 120 | No-operated | No | No | No | Alive |
12 | Non-Covered Methalic | 160 | No-operated | No | No | No | Alive |
13 | Non-Covered Methalic | 160 | No-operated | No | No | No | Alive |
14 | Non-Covered Methalic | 160 | No-operated | No | No | No | Alive |
15 | Non-Covered Methalic | 160 | No-operated | No | No | No | Alive |
16 | Non-Covered Methalic | 90 | No-operated | Yes | Yes ** | No | Exitus |
17 | Non-Covered Methalic | 70 | No-operated | Yes | Yes ** | No | Exitus |
18 | Non-Covered Methalic | 160 | No-operated | No | No | No | Alive |
four session
three session